scholarly journals Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4877 in Japanese Patients with Solid Tumors

2011 ◽  
Vol 4 (2) ◽  
pp. 23-31 ◽  
Author(s):  
Taito Esaki ◽  
Takashi Seto ◽  
Hiroshi Ariyama ◽  
Shuji Arita ◽  
Chinatsu Fujimoto ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients

scholarly journals Erratum to: Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

2013 ◽  
Vol 32 (2) ◽  
pp. 388-388
Author(s):  
Yu Sunakawa ◽  
Junji Furuse ◽  
Takuji Okusaka ◽  
Masafumi Ikeda ◽  
Fumio Nagashima ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients

A phase I study of resminostat in Japanese patients with advanced solid tumors

2015 ◽  
Vol 75 (6) ◽  
pp. 1155-1161 ◽  
Author(s):  
Satoru Kitazono ◽  
Yutaka Fujiwara ◽  
Shinji Nakamichi ◽  
Hidenori Mizugaki ◽  
Hiroshi Nokihara ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients ◽  
Advanced Solid Tumors

scholarly journals A Phase I study of intravenous PI3K inhibitor copanlisib in Japanese patients with advanced or refractory solid tumors

2016 ◽  
Vol 79 (1) ◽  
pp. 89-98 ◽  
Author(s):  
Toshihiko Doi ◽  
Nozomu Fuse ◽  
Takayuki Yoshino ◽  
Takashi Kojima ◽  
Hideaki Bando ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients ◽  
Pi3k Inhibitor

Abstract A167: A phase I study of single-agent BEZ235 (SDS sachet), once- or twice-daily, in Japanese patients with advanced solid tumors.

2013 ◽  
Author(s):  
Koichiro Watanabe ◽  
Hironobu Minami ◽  
Satoshi Otsu ◽  
Yoshinori Hirashima ◽  
Ryotaro Morinaga ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Single Agent ◽  
Japanese Patients ◽  
Advanced Solid Tumors

scholarly journals A phase I study of ontuxizumab, a humanized monoclonal antibody targeting endosialin, in Japanese patients with solid tumors

2019 ◽  
Vol 37 (5) ◽  
pp. 1061-1074 ◽  
Author(s):  
Toshihiko Doi ◽  
Takeshi Aramaki ◽  
Hirofumi Yasui ◽  
Kei Muro ◽  
Masafumi Ikeda ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients ◽  
Humanized Monoclonal Antibody ◽  
Antibody Targeting

scholarly journals Phase I study of single-agent ribociclib in Japanese patients with advanced solid tumors

2017 ◽  
Vol 109 (1) ◽  
pp. 193-198 ◽  
Author(s):  
Toshihiko Doi ◽  
Becker Hewes ◽  
Tomoyuki Kakizume ◽  
Takeshi Tajima ◽  
Norifumi Ishikawa ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Single Agent ◽  
Japanese Patients ◽  
Advanced Solid Tumors

Phase I study of BMS-247550 (ixabepilone) given every 3 weeks in Japanese patients with refractory solid tumors

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 2050-2050 ◽  
Author(s):  
T. Shimizu ◽  
N. Yamamoto ◽  
Y. Fujisaka ◽  
Y. Yamada ◽  
T. Sakamoto ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients

scholarly journals Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

2013 ◽  
Vol 32 (1) ◽  
pp. 104-112 ◽  
Author(s):  
Yu Sunakawa ◽  
Junji Furuse ◽  
Takuji Okusaka ◽  
Masafumi Ikeda ◽  
Fumio Nagashima ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients

Phase I study of LY2603618, a CHK1 inhibitor, in combination with gemcitabine in Japanese patients with solid tumors

2015 ◽  
Vol 26 (10) ◽  
pp. 1043-1053 ◽  
Author(s):  
Toshihiko Doi ◽  
Takayuki Yoshino ◽  
Kohei Shitara ◽  
Nobuaki Matsubara ◽  
Nozomu Fuse ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients ◽  
Chk1 Inhibitor
Sign in / Sign up

Export Citation Format

Share Document